Biodefense Market Size, Share & Trends Analysis Report and Segment
Forecast, 2025| Grand View Research, Inc
“The global biodefense market size was valued at USD 5.47 billion in 2018 and is
anticipated to expand at a CAGR of 4.5 % over the forecast period.”
The global Biodefense Market size is expected to reach USD 6.50 billion by 2025, growing at a CAGR of 4.5%
over the forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven
by rising focus of the public agencies on mitigating the risk of Chemical, Biological, Radiological and Nuclear
(CBRN) threats and increased funding for biodefense. Biomedical Advanced Research and Development
Authority (BARDA), National Interagency Confederation for Biological Research (NICBR), and National Institute
of Allergy and Infectious Diseases (NIAID) are major organizations that provide financial support for biodefense
research and stockpiling in U.S.
Ongoing research for the development of vaccinations and anti-toxins against biological threats, such as Zika
virus, is also one of the key drivers contributing to the market growth. For instance, Ohio State University is
undertaking a progressive research to develop a vaccine against the Zika virus that has proven beneficial results
in the mice models. According to a survey, in Brazil, around 2,952 confirmed cases of Zika-related microcephaly
in newborns were reported. Thus, rising risk of biological threats and subsequently rising R&D funding are
augmenting the growth of this market.
Presence of EUA policy in U.S. is also positively impacting the market growth. The EUA policy empowers FDA
Commissioners to allow and authorize the usage of a medical product(s) for commercial use, at the time of a
declared emergency in the country posing a threat to public health, that are currently unapproved or an
application of an approved medical product for a particular indication is unapproved by the FDA. The
government agencies issued the EUA policy for antiviral drugs to fight against diseases, such as Zika virus
infection and swine flu.
Follow Us:
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/biodefense-market
Further key findings from the study suggest:

Anthrax held the largest share in 2018 owing to increased investments by government agencies and
collaborations between public and private companies to develop and stockpile anthrax vaccines

Others segment consists of chemical and biological products. It accounted for the second-largest
revenue share in 2018

Small pox is expected to be the fastest-growing product segment of the global biodefense market over
the forecast period

North America was the largest regional market owing to favorable government initiatives and funding in
the field of biodefense

Europe is expected to witness the maximum growth rate from 2019 to 2025 on account of growing
focus of the European countries to enhance the preparedness against CBRN threats

Some of the key companies in the global market include PharmAthene, Inc.; Emergent BioSolutions, Inc.;
SIGA Technologies, Inc.; and Xoma Corporation
Grand View Research has segmented the global biodefense market on the basis of product and region:
Biodefense Product Outlook (Revenue, USD Million, 2014 - 2025)

Anthrax

Small Pox

Botulism

Radiation/Nuclear

Others
Biodefense Regional Outlook (Revenue, USD Million, 2014 - 2025)


North America
o
U.S.
o
Canada
Europe
Follow Us:



o
U.K.
o
Germany
o
France
o
Spain
o
Italy
o
Russia
Asia Pacific
o
Japan
o
China
o
India
o
Australia
o
Singapore
o
South Korea
Latin America
o
Brazil
o
Mexico
o
Argentina
Middle East & Africa
Follow Us:
o
South Africa
o
Saudi Arabia
o
UAE
Table of Content of Biodefense Market
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research:
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Biodefense Market Outlook, 2014 - 2025 (USD Million)
2.2 Biodefense Segment Outlook, 2014 - 2025 (USD Million)
2.3 Biodefense Competitive Insights Outlook, 2014 - 2025 (USD Million)
Chapter 3 Biodefense Market Variables, Trends & Scope
3.1 Biodefense Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis
3.4 User Perspective Analysis
3.4.1 End-user behaviour analysis
3.4.2 Market influencer analysis
3.5 List of Key End-users
3.6 Technology Overview
3.6.1 Technology timeline
3.7 Regulatory Framework
Follow Us:
3.7.1 Standards and compliances
3.8 Biodefense Market Dynamics
3.8.1 Market driver analysis
3.8.2 Market restraint analysis
3.8.3 Industry challenges
3.9 Biodefense Market Analysis Tools
3.9.1 Industry analysis - Porter’s
3.9.1.1 Supplier power
3.9.1.2 Buyer power
3.9.1.3 Substitution threat
3.9.1.4 Threats from new entrant
3.9.1.5 Competitive rivalry
3.9.2 PESTEL analysis
3.9.2.1 Political landscape
3.9.2.2 Enviornmental landscape
3.9.2.3 Social landscape
3.9.2.4 Technology landscape
3.9.2.5 Economic landscape
3.9.2.6 Legal landscape
3.9.3 Major deals & strategic alliances analysis
3.9.3.1 Joint ventures
3.9.3.2 Mergers & acquisitions
3.9.3.3 Strategic partnerships
3.9.4 Market entry strategies
Chapter 4 Biodefense Market- Competitive Analysis
4.1 Recent developments & impact analysis, by key market participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 Key Customers
4.3.2. Funding outlook
4.4 Public Companies
Follow Us:
4.4.1 Company market position analysis
4.4.2 Company ranking, by region
4.5 Private Companies
4.5.1 List of key emerging companies /technology disruptors/innovators
4.5.2 Regional network map
4.5.3 Company market position analysis
Chapter 5 Biodefense Market: Product Estimates & Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2018 & 2025
5.3 Segment Dashboard
5.4 Global Biodefense Market Revenue Estimates and Forecasts, by Product, 2014 - 2025 (USD Million)
5.4.1 Anthrax
5.4.1.1 Anthrax market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.2 Small pox
5.4.2.1 Small Pox Market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.3 Botulism
5.4.3.1 Botulism market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.4 Radiation/Nuclear Defense
5.4.4.1 Radiation/nuclear defense market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.5 Others
5.4.5.1 Others market revenue estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Biodefense Market: Regional Estimates & Trend Analysis, By Product
6.1 Regional Biodefense Market Snapshot, 2018 & 2025 (market size, CAGR, top verticals, top trends)
6.2 Leading Players, by Region, 2018
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East & Africa
6.3 North America
6.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
Follow Us:
6.3.2 U.S.
6.3.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.3.3 Canada
6.3.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4 Europe
6.4.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.2 U.K.
6.4.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.3 Germany
6.4.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.4 France
6.4.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.5 Spain
6.4.5.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.6 Italy
6.4.6.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.4.7 Russia
6.4.7.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5 Asia Pacific
6.5.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.2 Japan
6.5.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.3 China
6.5.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.4 India
6.5.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.5 Australia
6.5.5.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.6 Singapore
6.5.6.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.5.7 South Korea
Follow Us:
6.5.7.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6 Latin America
6.6.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6.2 Brazil
6.6.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6.3 Mexico
6.6.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.6.4 Argentina
6.6.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7 MEA
6.7.1. Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7.2 South Africa
6.7.2.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7.3 Saudi Arabia
6.7.3.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.7.4 UAE
6.7.4.1 Market revenue estimates and forecasts, by product, 2014 - 2025 (USD Million)
6.8 SWOT Analysis, by Factor
6.8.1 North America
6.8.2 Europe
6.8.3 Asia Pacific
6.8.4 Latin America
6.8.5 Middle East & Africa
Chapter 7 Competitive Landscape
7.1 Company Profiles
7.1.1 Xoma Corporation
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Altimune, Inc. (PharmAthene, Inc.)
Follow Us:
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Emergent Biosolutions Inc.
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Dynavax Technologies Corporation
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 SIGA Technologies, Inc.
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Elusys Therapeutics, Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 B.Ichor Medical Systems
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Dynport Vaccine Company LLC
7.1.8.1 Company overview
Follow Us:
7.1.8.2 Financial performance
7.1.8.3 Product benchmarking
7.1.8.4 Strategic initiatives
7.1.9 Cleveland Biolabs
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product benchmarking
7.1.9.4 Strategic initiatives
7.1.10 Bavarian Nordic
7.1.10.1 Company overview
7.1.10.2 Financial performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 Achaogen, Inc
7.1.11.1 Company overview
7.1.11.2 Financial performance
7.1.11.3 Product benchmarking
7.1.11.4 Strategic initiatives
7.1.12 Nanotherapeutics, Inc.
7.1.12.1 Company overview
7.1.12.2 Financial performance
7.1.12.3 Product benchmarking
7.1.12.4 Strategic initiatives
7.1.13 Alnylam Pharmaceuticals, Inc.
7.1.13.1 Company overview
7.1.13.2 Financial performance
7.1.13.3 Product benchmarking
7.1.13.4 Strategic initiatives
7.2 List of other companies
Follow Us:
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The global biodefense market size is expected to reach USD 6.50 billion by 2025